News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sanofi-Aventis (France) (SASY.PA) Settles with Sandoz Pharmaceuticals, Teva Pharmaceutical Industries Limited (TEVA) on Eloxatin Patent


4/1/2010 6:40:27 AM

Reuters -- French drugmaker Sanofi-Aventis (SASY.PA) has settled a patent law suit over cancer drug Eloxatin, putting a block on several other drugmakers selling their generic versions from late June until August 2012.

Read at Reuters

comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES